Advanced Search

Technical Analysis for SURF - Surface Oncology, Inc.

Grade Last Price % Change Price Change
grade C 4.7 1.73% 0.08
SURF closed up 1.73 percent on Friday, June 5, 2020, on 23 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
4 Watchers
Watchlist Portfolio

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical SURF trend table...
Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 1.73%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.73%
Narrow Range Bar Range Contraction 1.73%
NR7 Range Contraction 1.73%
Older EOD signals for SURF ...
View Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators
SURF Chart by TradingView
Basic chart:

Profile

Surface Oncology is a clinical-stage immuno-oncology company developing next-generation antibody therapies focused on the tumor microenvironment with lead programs targeting CD47 and CD73. Surface’s novel cancer immunotherapies are designed to achieve a clinically meaningful and sustained anti-tumor response, alone or in combination with other therapies. The company has a pipeline of immunotherapies and a strategic collaboration with Novartis focused on up to three next-generation cancer immunotherapies.
Medicine Medical Specialties Clinical Medicine Immunotherapy Cancer Treatments Virotherapy Cancer Immunotherapy Tumor Immunotherapies Cancer Research Active Immunotherapy CD47 Next Generation Cancer Novel Cancer

Is SURF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
May 28 Surface Oncology Announces Change to Location and Format of 2020 Annual Meeting of Stockholders
May 22 Surface Oncology -2.1% after equity sales agreement
May 22 The Daily Biotech Pulse: FDA Nod For Aquestive, Tetraphase M&A Plot Thickens, Amarin's Vascepa In COVID Fray
May 21 The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive
May 20 Mid-Afternoon Market Update: Crude Oil Up 5%; Surface Oncology Shares Spike Higher
May 20 Why Surface Oncology's Stock Is Surging Higher
May 20 Mid-Day Market Update: Xcel Brands Jumps After Q1 Results; Pyxus International Shares Slide
May 20 P/E Ratio Insights for Surface Oncology
May 20 Mid-Morning Market Update: Markets Open Higher; Lowe's Tops Q1 Estimates
May 20 Surface Oncology teams up with Merck in cancer study; shares up 35%
See more SURF news...

Indicators

Indicator Value
52 Week High 7.66
52 Week Low 1.15
Average Volume 2,195,121
200-Day Moving Average 2.34
50-Day Moving Average 3.01
20-Day Moving Average 3.99
10-Day Moving Average 4.87
Average True Range 0.58
ADX 41.79
+DI 38.09
-DI 13.12
Chandelier Exit (Long, 3 ATRs ) 5.93
Chandelier Exit (Short, 3 ATRs ) 4.12
Upper Bollinger Band 6.27
Lower Bollinger Band 1.71
Percent B (%b) 0.65
BandWidth 114.18
MACD Line 0.58
MACD Signal Line 0.57
MACD Histogram 0.0059
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.08
Resistance 3 (R3) 5.06 4.93 5.01
Resistance 2 (R2) 4.93 4.83 4.93 4.99
Resistance 1 (R1) 4.81 4.77 4.87 4.83 4.97
Pivot Point 4.68 4.68 4.71 4.68 4.68
Support 1 (S1) 4.56 4.58 4.62 4.58 4.43
Support 2 (S2) 4.43 4.52 4.43 4.41
Support 3 (S3) 4.31 4.43 4.39
Support 4 (S4) 4.33